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ABSTRACT  We have prepared  a monoclonal  antibody,  named MZ15, that specifically  binds 
keratan sulfate. Immunofluorescence  studies showed  that the distribution  of keratan sulfate 
in articular  cartilage was not  uniform:  the amount of keratan sulfate increased with distance 
from the articular  surface. Two subpopulations  of chondrocytes  could be distinguished  after 
isolation  from  cartilage  by the  presence or absence of cell  surface keratan sulfate. Keratan 
sulfate-negative  chondrocytes  were shown to come  from  the  upper cartilage layers. There 
was therefore  a direct correlation  between biochemical  heterogeneity  of cartilage matrix and 
heterogeneity  within  the  chondrocyte  population.  During  growth  in  monolayer  culture, 
superficial  chondrocytes  began to  synthesize  keratan sulfate, but  the  cells could  still  be 
distinguished from cultures of deep or unfractionated  chondrocytes  by their reduced substrate 
adhesiveness and tendency to remain rounded. 
Mature articular cartilage is avascular and lacks innervation. 
It contains a  single differentiated cell type, the chondrocyte, 
which secretes a matrix predominantly of type II collagen and 
specific proteoglycans. Despite this apparent simplicity, how- 
ever, the tissue is far from homogeneous. Both the ultrastruc- 
ture of the chondrocytes and the composition of their extra- 
cellular matrix vary with distance from the articular surface. 
Several distinct zones of articular cartilage can be distin- 
guished on the basis of chondrocyte morphology and distri- 
bution. The superficial zone contains a thin layer of elongated 
chondrocytes. Beneath this, the middle zone contains oval or 
rounded  cells distributed at random.  The  third, deep, zone 
contains groups of large, rounded cells, sometimes arranged 
in columns perpendicular to the tissue surface. Finally, there 
is a thin layer of calcifying cells adjacent to bone. 
The  packing and  orientation of collagen fibers vary with 
depth in articular cartilage, and fiber diameter is greatest in 
the  middle  and  deep  zones  (9,  26,  27).  The  amount  of 
proteoglycan, its monomer size, glycosaminoglycan content, 
and  degree  of aggregation with  hyaluronic acid all change 
with distance from the articular surface (1, 8, 20, 27). Such 
variation  in  biochemical composition in  turn  accounts  for 
changes in the physical properties of the tissue with depth ( 17, 
18). 
One explanation for the observed matrix heterogeneity is 
that it reflects intrinsic differences between the chondrocytes 
of different zones.  However, until  now,  direct evidence for 
this has been lacking. In the present study we used a  mono- 
clonal  antibody  to  keratan  sulfate,  MZ15,  to  identify two 
distinct subpopulations of differentiated chondrocytes, both 
in cartilage and after isolation from the tissue. We separated 
keratan sulfate-positive and -negative chondrocytes and grew 
them  in  culture,  to  discover  whether  the  keratan  sulfate 
phenotype is stable. 
MATERIALS AND  METHODS 
Chondrocyte Isolation and Culture:  Cartilagewasdissected  from 
the larynx and trotters of 9-mo-old bacon  pigs,  rinsed in  PBS,  and  finely 
chopped. Laryngeal cartilage  was stripped of perichondrium before chopping. 
Chondrocytes were released  from surrounding matrix by sequential digestion 
at 37"C with the following  enzymes (Sigma Chemical Co., St. Louis, Mo): 
0.01% hyaluronidase  (20 min); 0.1% pronase (I h); 0.25% collagenase  (I h); 
and 0.25% collagenase  ( 1 h). Any cells released  by hyaluronidase  or pronase 
were discarded.  Cells  obtained from the two incubations  with collagenase  were 
pooled and passed through a screen of nylon filter cloth (60-urn aperture; 
Cadisch  and Sons, London)  to remove  undigested  matrix.  Cells  were considered 
viable  if they excluded  a 0.25% solution  of trypan blue. 
The chondrocyte  culture medium was Dulbecco's  modified  Eagle's  medium 
(DME) t containing 10% fetal  calf serum. For monolayer  culture, 106 cells  were 
plated out per 35-mm-diam petri dish (Falcon Labware, Oxnard, CA), and 
glass coverslips  were added if required for immunofluorescence.  Chondrocytes 
~Abbreviation used in this paper: DME, Dulbecco's modified Eagle's 
medium. 
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were also grown in suspension  in  1.3% methyl cellulose (a generous gift of 
Colorcon  Ltd., Orpington,  England;  reference 30)  in  DME  containing  one- 
third  of the  normal concentration  of calcium  ions,  in  order  to reduce  cell 
clumping.  Suspended cells were harvested by centrifugation  after dilution  of 
methyl cellulose with phosphate-buffered saline (PBS). 
Preparation  and  Screening  of  Monoclonal  Antibodies: 
After overnight  incubation  in  spinner  culture,  laryngeal chondrocytes  were 
collected by centrifugation and washed once in PBS. We resuspended the cells 
in PBS and complete Freund's adjuvant (Difco Laboratories Inc., Detroit, MI) 
and injected 2.5  x  107 cells at multiple subcutaneous  sites into each BALB/c 
mouse. Mice received two booster injections, each of 1.5-2.0  x  107 cells, in 
PBS alone, and were killed 3 d after the final injection. 
Spleen cells from an immunized mouse were fused with NSI myeloma ceils, 
using conventional  procedures  (19). We tested supernatants  from the hybrid 
cultures for the presence of antibodies  reacting with glutaraldehyde  fixed pig 
chondrocytes,  but not pig dermal  fibroblasts or lymphocytes, in an enzyme- 
linked immunosorbent assay. Selected clones were subcloned by limiting dilu- 
tion and retested for chondrocyte-specific reactivity. Clones were further prop- 
agated in ascites in Pristane (Aldrich Chemical Co., Ltd., Gillingham, England) 
primed mice. MZI5, the antibody described in this report, was shown to be a 
class 1 IgG by immunodiffusion  against class and subclass-specific antisera. 
Preparation  of  Proteoglycans  and  Proteoglycan  Frag- 
ments:  Proteoglycans were extracted from pig laryngeal cartilage with 4 M 
guanidinium  chloride in 0.05 M sodium acetate, pH 5.8, with added proteinase 
inhibitors, as described previously (12). We performed associative equilibrium 
density gradient  centrifugation  on the extract  and recentrifuged the bottom 
fraction (A l) containing proteoglycan aggregate to give a more purified proteo- 
glycan  aggregate preparation  (AIAI).  Proteoglycan  binding  region,  keratan 
sulfate-rich  region, and  the stubs of chondroitin  sulfate chains  attached  to 
peptide were obtained by digestion of  the AIAI preparation with chondroitinase 
ABC (Miles Laboratories Inc., Elkhart, IN) and trypsin (Sigma Chemical Co.). 
The fragments were separated by chromatography  on Scpharose CL6B (Phar- 
macia Fine Chemicals, Uppsala, Sweden) (16) and binding region was further 
purified as described by Ratcliffe and Hardingham (28). 
Proteoglycan monomer was separated from other components of proteogly- 
can aggregate by equilibrium density gradient centrifugation under dissociative 
conditions (12), the bottom fraction containing purified proteoglycan monomer 
(AIAIDI). Reduction  and  alkylation  of the monomer was performed  as de- 
scribed by Hardingham  et al. (14). Proteoglycan core protein was prepared by 
digestion of the monomer with chondroitinase  ABC and purified by chroma- 
tography on Sepharose CL2B (Pharmacia  Fine Chemicals; reference 16). Pro- 
teoglycan monomer fragments and bovine corneal keratan sulfate (Miles Lab- 
oratories  Inc.) were digested with keratanase (Miles Laboratories Inc.), essen- 
tially as described by Pike et at. (24). Proteogiycan monomer from rat chon- 
drosarcoma was isolated by the method of Oegema et al. (23). 
Radioimmunoassay:  Inhibition  mdioimmunoassay  was performed 
as described previously (28), with the  following modifications: the iodinated 
antigen  was  J2~I-AIAIDI;  antibody-antigen  complexes  were  incubated  with 
Staphylococcus aureus for 2 h; S. aureus was suspended in distilled water and 
complexes bound to At aureus were washed with distilled water. MZ 15 ascitic 
fluid could precipitate >80% of ~2~I-AIAID1.  A 1:25,000 dilution, which bound 
40% of  the ~2~I-AIAIDI,  was used in the radioimmunoassay, and the minimum 
amount of material that could be detected was 5 fmol. 
We compared the inhibitory activity of proteogiycan fragments on a molar 
basis. We calculated concentrations  of inhibitors  by assuming  the  following 
protein  molecular  weights: proteoglycan  monomer, 2 x  102; binding  region, 
5.5 x  104; keratan sulfate region, 4 x  104; and chondroitin  sulfate peptides, 5 
x  10;. 
Immunofluorescence:  For frozen sections, unfixed tissue was chilled 
rapidly in hexane to <-70"C; 8-10-#m sections were then cut with a cryostat 
and air-dried at room temperature before staining. All tissues were from mature 
animals  except for those  isolated from  17-d chick embryos.  For cell surface 
staining, cultured chondrocytes in suspension were fixed in 3.7% formaldehyde 
in PBS at room temperature  for 8 rain.  For intracellular staining of chondro- 
cytes grown on glass coverslips, formaldehyde fixation was followed by incu- 
bation in absolute methanol on ice for 5 rain. 
Cells or tissue sections were incubated in MZI 5 (aseitic fluid diluted 1:1,000 
in PBS) or rabbit anti-pig type II collagen (diluted  1:20; antiserum generously 
provided by V. Duance, Meat Research Institute, Bristol) at room temperature 
for 30  min, washed in  PBS, and incubated  in  fluorescein-conjugated rabbit 
anti-mouse IgG or fluorescein-conjugated goat anti-rabbit IgG (1:16 dilution; 
Miles Scientific) as before. After further washing in PBS, we examined speci- 
mens under a Zeiss photomicroscope  Ill, using incident  illumination.  When 
specimens were incubated with second antibody alone we observed no staining. 
Digestion of cartilage sections with 0.5  U/ml chondroitinase  ABC in PBS at 
37"C for 1 h, before incubation  with MZIS, did not enhance antibody binding. 
We determined  the proportion  of chondrocytes that stained positively with 
MZI 5 or type I1 collagen antiserum  from phase and fluorescence photographs 
of several microscopical fields selected at random. 
RESULTS 
MZI 5 Binds to Keratan  Sulfate 
Injection of whole chondrocytes into BALB/c mice and 
fusion of the spleen cells with NS1 cells yielded many hybrid 
clones that secreted antibodies that bound to whole chondro- 
cytes but  not  to  dermal  fibroblasts  or  lymphocytes. One 
hybridoma secreted IgGl  antibodies, designated MZ15, that 
recognized cartilage proteoglycan monomer (AIAIDI) in an 
enzyme-linked immunosorbent assay. 
The core protein of  cartilage proteoglycan has three separate 
domains: a highly folded globular region that forms the hy- 
aluronic acid-binding site; a short region that contains most 
of the attachment sites for keratan sulfate; and a larger chon- 
droitin sulfate-rich region (13). To locate the antibody bind- 
ing sites  of MZI5  more  precisely, we  used  an  inhibition 
radioimmunoassay to determine the ability of various unla- 
beled  proteoglycan  fragments  to  compete  with  iodinated 
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FIGURE  1  Competitive  inhibi- 
tion  radioimmunoassay,  showing 
ability of unlabeled proteoglycan 
fragments  to  compete  with  ~2Sl- 
AIAIDI  for  binding to  MZ15.  (a) 
Keratan  sulfate-rich  region;  (b) 
reduced and alkylated AIAIDI; (c) 
AIAIDI after digestion with chon- 
droitinase  ABC;  (d)  AIAIDI;  (e) 
AIAIDI after keratanase digestion; 
(f)  keratan  sulfate-rich  region 
after keratanase digestion; (g) hy- 
aluronic acid-binding  region;  (h) 
hyaluronic  acid-binding  region 
after  keratanase  digestion;  (i) 
chondroitin  sulfate  peptides;  (j) 
rat chondrosarcoma  AIDI. 
54  THE  JOURNAL  OF  CELL BIOLOGY • VOLUME  101,  1985 Reduction and alkylation of  proteoglycan monomer, which 
destroys disulfide bonds that maintain the tertiary structure 
of  the hyaluronic acid-binding region, did not affect the ability 
of AIAIDI to compete effectively for MZ 15 binding (Fig.  1, 
curves b and d), and isolated binding region had only 5.5% 
of the inhibitory activity of intact monomer (Fig.  1, curve g). 
The inhibitory activity of chondroitin sulfate peptides was 
0.02%  of AIAIDI  (Fig.  I,  curve  i),  and  since  removal  of 
chondroitin sulfate with chondroitinase ABC did not reduce 
the antigenicity ofthe monomer(Fig. 1, curve c), chondroitin 
sulfate could  not  be the antigen  recognized by MZ15.  In 
contrast, the keratan sulfate-rich region of  proteoglycan  mon- 
omer did  retain  inhibitory activity (Fig.  1,  curve  a),  and 
keratanase digestion of either AIAIDI (Fig.  1, curve e) or the 
keratan sulfate-rich region (Fig.  1, curve f) caused a signifi- 
cant reduction in their ability to compete for MZ15 binding. 
The inhibitory activity of  the hyaluronic acid-binding region, 
which contains a small amount of  keratan sulfate, was reduced 
to 0.2% that of monomer by treatment with keratanase (Fig. 
1, curve h). Furthermore, proteoglycan from rat chondrosar- 
coma, which  contains no  keratan  sulfate,  did  not  bind  to 
MZI5 at all (Fig.  1, curve j). 
These results suggested  that the specificity of MZI 5 was 
towards keratan sulfate. To confirm this, we tested free kera- 
tan  sulfate chains in  the  inhibition radioimmunoassay.  As 
shown in Fig. 2, keratan sulfate was a strong inhibitor of I ~25- 
AIAIDI  binding  to  MZ15.  However, digestion  of keratan 
sulfate chains with keratanase reduced its inhibitory activity 
to < 1%. Thus, the antigenic determinant recognized by MZ 15 
is part of the keratan sulfate chain that is sensitive to keratan- 
ase digestion. 
Tissue and Species Cross-reactivity 
Keratan  sulfate  contains  a  repeating  disaccharide  of N- 
acetyl-glucosamine and galactose, and is classified  into two 
types on the basis of its linkage to protein: keratan sulfate I 
occurs in cornea and keratan sulfate II is found in cartilage 
and  intervertebral disc  (22).  We  tested  frozen sections  of 
various tissues from different species  for MZ 15 binding. As 
Table I and Fig. 3 show, the antibody had wide species cross- 
reactivity and recognized both skeletal and corneal keratan 
sulfate. 
Although MZ15 bound to mouse cornea, it did not stain 
mouse intervertebral disc or costal cartilage (Table I),  and 
proteoglycans  from these tissues did not have inhibitory activ- 
ity in the radioimmunoassay (results not shown). This sup- 
ports the conclusion, from biochemical analysis,  that mouse 
cartilage,  unlike cartilage of the other species tested, does not 
contain keratan sulfate (31 ). 
Distribution of Keratan Sulfate in Cartilage 
In  articular and  laryngeal cartilage  of the  species  tested 
(Table I) the distribution of keratan sulfate revealed by im- 
munofluorescence with MZ 15 was not uniform. In each case, 
there were areas of matrix surrounding chondrocytes near the 
tissue surface that did not bind the antibody (Fig. 3 a). These 
TABLE I.  Tissues  and Cells Stained with MZ15 
MZ15 
Animal  TissueJcells  staining 




Human  Articular cartilage and isolated chon-  + 
drocytes 
Skin (epidermis and dermis) 
Rabbit  Isolated articular chondrocytes  + 
Cornea  + 
Dog  Articular cartilage  + 
Chick  Sternal cartilage  + 
Cornea  + 
Mouse  Costal cartilage 
Lumbar intervertebral disc 




-~  so 
z 
# 
[ K ERATAN  SULFATE  ] (g/ml) 
FIGURE 2  Competitive  inhi- 
bition radioimmunoassay 
shows the ability of intact cor- 
neal keratan  sulfate  to  com- 
pete with 1251-AIAIDI  for bind- 
ing to MZ 15. 
FIGURE 3  Frozen sections  of unfixed tissue, stained  with MZ15. 
(a) Pig articular cartilage; (b) rabbit corneal epithelium and part of 
underlying stroma. Bar, 200 pm. x  115. 
ZANETTI ET AL.  ChondrocyteSubpopulations  ]~5 regions extended beyond the pericellular matrix and resem- 
bled teardrops in shape. This prompted us to examine whether 
chondrocytes isolated from different layers of  cartilage showed 
a corresponding variation in the amount of cell surface kera- 
tan sulfate. 
Keratan Sulfate on Freshly Isolated Chondrocytes 
Chondrocytes  from  full  thickness  pig  articular  cartilage 
were stained with MZI5 immediately after isolation. 50-60% 
of cells had surface keratan sulfate, some cells staining more 
intensely  than  others  (Table  II,  Fig.  4a).  All  staining  was 
abolished by treating chondrocytes with  trypsin or pronase 
before  fixation;  this  indicates  that  the  keratan  sulfate  was 
attached to protein. 
There  was  a  distinct  correlation  between  cell  size  and 
positive staining in freshly isolated chondrocytes: most of the 
cells that  did  not  bind  the  antibody were small.  Since  the 
upper layers of cartilage contain smaller cells and less keratan 
sulfate than  do the deeper zones (Fig.  3a),  we investigated 
whether small MZ 15-negative cells came from near the car- 
tilage surface. The  upper 20-30%  of articular cartilage was 
removed by dissection  and  the  chondrocytes were isolated. 
As  Fig.  4b  illustrates,  these  superficial  chondrocytes  were, 
indeed, smaller than chondrocytes from the deeper layers of 
cartilage, and most of them did not bind MZI5 (Table II). 
Chondrocytes were also isolated from cartilage that remained 
after  removal  of the  upper  layers  ("deep"  chondrocytes). 
However, because of the undulating surface of the cartilage, 
the upper layers had not been removed completely, and the 
proportion  of keratan  sulfate-positive cells was not  signifi- 
cantly increased (Table II). 
When superficial and deep chondrocytes were incubated in 
suspension overnight to allow resynthesis of matrix compo- 
nents (6) the intensity of staining with MZI5 increased (Fig. 
4 c). The proportion of cells with surface keratan sulfate also 
increased,  but  there  were  still  fewer  superficial  cells  that 
stained  positively than  there were deep cells  (Table II).  In 
contrast, the proportion of cells that stained positively with 
antiserum to type II collagen was the same in both populations 
(Table II, Fig. 4 d). 
The low proportion of superficial cells with surface keratan 
sulfate could  not  be explained by poor viability or loss of 
biosynthetic capacity, because superficial and deep chondro- 
cytes excluded trypan blue to the same extent (>95% imme- 
diately after isolation),  and  there  was  no  difference in  the 
proportion of cells synthesizing type II collagen after overnight 
TABLE  II.  Chondrocytes  in Suspension Stained with MZ15 or 
Antiserum  to Type II Collagen 
% Posi-  No. cells 
Cells*  Antibody  tive  counted 
Unfract. fresh  MZ15  54.5  1,057 
Superf. fresh  MZ15  15.5  1,324 
Deep fresh  MZ15  54.9  1,123 
Superf. o/n  MZl 5  36.4  618 
Deep o/n  MZ15  62.6  952 
Superf. o/n  Anti-type II collagen  83.7  602 
Deep o/n  Anti-type II collagen  82.8  458 
*Cells  were  isolated  from  full-thickness  (unfract.)  or superficial  (superf.)  car- 
tilage,  or  from  cartilage  remaining  after  removal  of superficial  cells  (deep), 
and prepared  for immunofluorescence  immediately  after isolation  (fresh)  or 
after overnight  incubation  in suspension  (o/n). 
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FIGURE 4  Pig articular chondrocytes in suspension. (a) Unfraction- 
ated,  freshly  isolated;  (b)  superficial,  freshly  isolated;  (c  and  d) 
superficial, overnight incubation. Stained with: (a-c) MZI 5, and (d) 
anti-type II collagen. Bar, 50 ~m. × 363. 
incubation in suspension (Table II). Furthermore, superficial 
chondrocytes were active in  proteoglycan synthesis: proteo- 
glycans from the upper layer of cartilage had the same mon- 
omer size and degree of aggregation, determined by chroma- 
tography on Sepharose 2B (13),  as proteoglycans from deep 
or unfractionated cartilage (results not shown). The presence or absence of surface keratan sulfate on chondrocytes there- 
fore reflects true heterogeneity within the cell population, and 
is related to the cells' position within the different layers of 
cartilage. 
Keratan Sulfate in Monolayer Cultures 
of Chondrocytes 
When  freshly isolated articular chondrocytes were plated 
out on glass coverslips or tissue-culture plastic, they attached, 
and spreading was complete within 2 d. Cells that had begun 
to spread sometimes had a  surface "cap" of keratan sulfate 
(Fig. 5 a) which appeared to be discarded when spreading was 
complete, because patches of keratan sulfate were visible on 
the substrate, some distance from fully spread cells (Fig. 5 b). 
However, new matrix synthesis was initiated  in  monolayer 
culture (7) and keratan sulfate was found at cell margins in 
the  center of young colonies (Fig.  5,  c and  d).  MZ15  also 
decorated  a  region  of the  cytoplasm close  to  the  nucleus, 
corresponding  to  the  Golgi  region  (Fryer,  P.  R.,  and  A. 
Ratcliffe, unpublished observations). A  few cells with intra- 
cellular staining had no surface keratan sulfate (Fig.  5 c). 
To discover whether the keratan sulfate phenotype of s-u- 
perficial and deep chondrocytes was stable during monolayer 
culture,  the  proportion  of cells from each population with 
intracellular or surface keratan sulfate was assessed at intervals 
after plating. Under the culture conditions used, chondrocytes 
continued to synthesize aggregatable proteoglycan of  the same 
monomer size as in  cartilage for at  least 21  d  (results  not 
shown).  Cell  number per dish  doubled  within  7  d  and  re- 
mained constant thereafter. 
Within  two  days  of plating,  most  of the  chondrocytes 
derived from the upper cartilage layers stained positive with 
MZ15.  By  confluence,  the  proportion  of keratan  sulfate- 
positive cells appeared to be the same in superficial and deep 
cultures and remained unchanged at about 60-70% for up to 
21  d  in  culture  (Fig.  6,  a  and  c).  Although  the  two  cell 
populations could no longer be distinguished by MZ 15 stain- 
ing when grown in monolayer culture, they did show consist- 
ent differences in culture morphology. Superficial chondro- 
cytes adhered less strongly to the culture substrate during the 
first 2  d  after plating, and tended to remain more rounded 
than did deep or unfractionated chondrocytes throughout the 
21-d culture period (Fig. 6, b and d). 
DISCUSSION 
Until recently, localization of specific glycosaminoglycans by 
microscopy relied on indirect methods, such as histochemical 
staining (21,  29)  or a  combination of autoradiography and 
digestion with specific enzymes (15).  Now, however, mono- 
clonal antibodies to individual glycosaminoglycans are avail- 
able (4, 5) and these allow precise and rapid localization by 
immunofluorescence. This paper describes MZ15,  a  mono- 
clonal  antibody  that  recognizes  both  skeletal  and  corneal 
keratan  sulfate  and  has  wide  species  cross-reactivity.  The 
antigenic  site  is  sensitive  to  keratanase  digestion,  which 
cleaves keratan sulfate chains predominantly into disaccha- 
rides (24).  Thus, MZ15 binding depends on glycosaminogly- 
can  chain  length.  This  antibody  appears  to  have  similar 
properties to one recently described by Caterson et at. (4). 
We have used MZI5 to demonstrate directly the distribu- 
tion of keratan sulfate in articular cartilage. The results con- 
firm previous histochemical (21, 29) and biochemical (1, 20) 
FIGURE  5  (a) Chondrocyte spreading.  Note "cap" of keratan  sul- 
fate. (b) Keratan sulfate on culture substrate (arrow).  (a and b) Bar, 
50  urn.  x  540.  (c  and  d)  Small  colony  of  chondrocytes.  Note 
pericellular matrix (thick arrow) and Golgi regions (thin arrows). Bar, 
50/zm. x  560. 
evidence that the amount of keratan sulfate in cartilage in- 
creases with depth. This, in turn, has been correlated with an 
increase  in  tissue  stiffness with  distance  from the  articular 
surface (18). 
ZANETTI  ET AL.  ChondrocyteSubpopulations  57 FIGURE 6  Chondrocytes grown in monolayer culture for 14 d were stained with MZ15. (a and b) Superficial and (c and d) deep 
chondrocytes.  Bar, 50 p.m. x  335. 
The  pattern  of MZ 15  staining  in  articular  cartilage  sug- 
gested that individual chondrocytes differ in their capacity for 
keratan sulfate synthesis. This was confirmed by the finding 
that only 50-60%  of chondrocytes, either freshly isolated or 
allowed to recover overnight in suspension, had surface ker- 
atan sulfate, as compared with 80-90% that stained positively 
for surface type II collagen. Furthermore, the cells that lacked 
surface keratan sulfate came from the upper layers of cartilage. 
The difference between superficial and deep chondrocytes 
cannot  be  explained  by  differences  in  viability  or  overall 
capacity  for  proteoglycan  and  type  II  collagen  synthesis. 
Rather,  it  represents intrinsic  heterogeneity within  the  cell 
population, which is reflected in the amount of keratan sulfate 
in different zones of articular cartilage. A similar correlation 
between heterogeneity of matrix composition and chondro- 
cytes has been found in the different types of collagen synthe- 
sized by cells isolated from calcifying and  noncalcifying re- 
gions of chick cartilage (3,  10). 
To  determine  whether  the  keratan  sulfate  phenotype  is 
stable when chondrocytes are grown  in  monolayer culture, 
superficial and deep chondrocytes were seeded at high density 
and stained with MZ15  at intervals after plating. At conflu- 
ence, the proportion of keratan sulfate-positive cells was the 
same in  both cell populations. This suggests  that superficial 
chondrocytes are capable of synthesizing keratan sulfate, but 
that synthesis is normally inhibited in the cartilage environ- 
ment. 
When chondrocytes are placed in monolayer culture, they 
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can  divide  and  spread,  make  extensive  contacts  with  one 
another, and initiate new synthesis of matrix components (6, 
7).  It is perhaps not  surprising,  therefore,  that  the  cells  no 
longer synthesize the same matrix components as they do in 
situ in cartilage. It would clearly be of interest to determine 
culture conditions under which superficial chondrocytes did 
not  initiate  keratan  sulfate  synthesis.  In  this  context,  it  is 
interesting that Vertel and Barkman (32) have noted individ- 
ual chick chondrocytes in culture that do not contain keratan 
sulfate, even though they are synthesizing chondroitin sulfate 
proteoglycan. 
Although superficial and deep chondrocytes ceased to differ 
with  respect  to  keratan  sulfate synthesis during  monolayer 
culture, some difference in culture morphology was evident. 
Superficial chondrocytes appeared to attach less strongly to 
the  culture  substrate  and  showed  less  tendency  to  spread. 
Maintenance  of rounded  morphology  has  been  linked  to 
stability of the differentiated phenotype of chondrocytes (2, 
I l, 25,  33) and it remains to be determined whether the two 
subpopulations differ in this respect. 
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